Marc Appel

Founder and Entrepreneur in Residence at Orange Grove Bio and Yale Ventures

Speaker

As an experienced investor in the healthcare and biotech spaces, Marc Appel, JD, MBA, helped to build the structured healthcare and royalty investing strategy at Marathon Asset Management, where he was instrumental on a range of large biotech deals. Prior to that, he invested across the capital structure in public market healthcare opportunities in the specialty pharma, hospital, outpatient services, drug distribution, and biotech sectors.

Previously, Marc held roles at Highbridge Principal Strategies, Eaton Vance, and Kirkland & Ellis. He began his career as an analyst at McKinsey & Co., serving a mix of financial services and healthcare clients.

Marc speaks on many industry panels and conferences, including those hosted by universities, BIO, RESI, CBI, and PBMI. He has also written a Harvard Business School case study on Imprimis Pharmaceuticals and has lectured at Harvard Business School, Harvard Law School, and Stern School of Business at New York University.

Marc received his B.A. from Yale University, summa cum laude, his J.D. from Harvard Law School, and his M.B.A. from Harvard Business School. He is an active member of the New York Bar.